Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1500 GMT/11 AM ET

Thu, 19th Apr 2018 16:23

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Allergan moves in as Shire rebuffs $63 bln Takeda bid-sources

LONDON/NEW YORK - Drugmaker Shire has rejected a thirdtakeover bid worth nearly $63 billion from Japan's TakedaPharmaceutical, although talks are continuing, while sources sayAllergan is also in competing negotiations. (SHIRE-M&A/TAKEDAPHARMA-BID (UPDATE 2), moved, by Greg Roumeliotis, Ben Hirschlerand Ben Martin, 550 words)

EXCLUSIVE-China looks to speed up chip plans as U.S. tradetensions boil -sources

BEIJING - China is looking to accelerate plans to developits domestic semiconductor market amid a fierce trade stand-offwith the United States and a U.S. ban on sales to Chinese phonemaker ZTE that has underscored the country's reliance onimported chips. (USA-TRADE/CHINA-CHIPS (EXCLUSIVE), moved, byElias Glenn and Cate Cadell, 600 words)

P&G to buy German Merck's consumer health unit for $4.2 bln

Procter & Gamble Co will acquire the consumer healthbusiness of Merck KGaA for $4.2 billion, giving it vitaminbrands such as Seven Seas and greater exposure to Latin Americanand Asian markets. (MERCK-M&A/P&G (UPDATE 3, PIX), moved, 450words)

MARKETS

Apple, P&G and chip stocks lead Wall St lower

U.S. stock are lower, pulled down by a broad-based slump intechnology stocks from Apple to chipmakers as well as a tumblein consumer staples such as Procter & Gamble. (USA-STOCKS/(UPDATE 3), updated throughout the day, 420 words)

+ See also:

- GLOBAL-MARKETS/ (WRAPUP 4, PIX), updated throughout theday, 830 words

Oil climbs on Saudi price ambitions and U.S. stocks draw

LONDON - Oil prices keep rising to their highest since late2014 as U.S. crude inventories decline, moving closer tofive-year averages, and after sources tell Reuters that topexporter Saudi Arabia aims to push prices even higher.(GLOBAL-OIL/ (UPDATE 7, PIX), updated throughout the day, 430words)

TRADE/ECONOMY

U.S. weekly jobless claims dip in latest week

WASHINGTON - New applications for U.S. unemployment benefitsfell last week, indicating continued job growth after a slowdownin March. (USA-ECONOMY/UNEMPLOYMENT, moved, 340 words)

China says ready to deal with any fallout from U.S. traderow

BEIJING - China is well prepared to handle any negativeeffects from its trade dispute with the United States, thecommerce ministry says, adding that Beijing's tariff hikes onU.S. imports will not have a big impact overall on its domesticindustries. (USA-TRADE/CHINA (WRAPUP 1, TV), moved, by YawenChen and Se Young Lee, 490 words)

Trump, Japan's Abe agree to intensify trade talks

PALM BEACH - U.S. President Donald Trump and Japanese PrimeMinister Shinzo Abe say they have agreed to intensify tradeconsultations between the two longtime allies, with an aim toexpand investment and trade between their countries.(USA-JAPAN/TRADE-IMBALANCES (UPDATE 3), moved, by Steve Holland,500 words)

COMPANIES

As Bon-Ton liquidates, U.S. department stores vie for itsshoppers

With the disappearance of Bon-Ton, which won courtpermission on Wednesday to liquidate, rivals such as Macy's Inc,J.C. Penney Co Inc and Kohls Corp will compete to keep longtimecustomers from turning to discounters like Walmart Inc or onlinejuggernaut Amazon.com Inc. (BON TON STORES-BANKRUPTCY/ (REPEAT),moved, by Tracy Rucinski and Melissa Fares, 480 words)

Nucor profit beats estimates on higher prices, shipments

Nucor Corp reported a higher-than-expected quarterly profitas its shipments and selling price increased, and the company,the No. 1 U.S. steelmaker by market value, forecast asignificant increase in second-quarter profit on a sequentialbasis. (NUCOR-RESULTS/ (UPDATE 1), moved, 210 words)

Market swings knock Blackstone earnings less than feared

Blackstone Group LP, the largest manager of alternativeassets such as private equity and real estate, on Thursdayreported a 20 percent drop in first-quarter earnings per sharebut still beat Wall Street's expectations, as a stock marketslump weighed on the value of its holdings. (BLACKSTONEGROUP-RESULTS/ (UPDATE 1), moved, by Joshua Franklin, 360 words)

China's ZTE removed chief compliance officer before U.S.sanction -source

HONG KONG - ZTE Corp's chief compliance and chief legalofficer was removed from his posts more than a month before theChinese telecom equipment maker was slapped with U.S. sanctionsthis week, a company source with direct knowledge of thesituation told Reuters. (USA-CHINA/ZTE (PIX), moved, by SijiaJiang, 370 words)

+ See also:

- USA-CHINA/ZTE-RIVALS, moved, by Olof Swahnberg and EricAuchard, 770 words

EXCLUSIVE-Facebook to put 1.5 billion users out of reach ofnew EU privacy law

SAN FRANCISCO - If a new European law restricting whatcompanies can do with people's online data went into effecttomorrow, almost 1.9 billion Facebook Inc users around the worldwould be protected by it. The online social network is makingchanges that ensure the number will be much smaller.(FACEBOOK-PRIVACY/EU (UPDATE 1, EXCLUSIVE, PIX), moved, by DavidIngram, 750 words)

Novartis CEO feels heat on U.S. generics, Cosentyx drop

ZURICH - Swiss drugmaker Novartis' first quarterly resultsunder new Chief Executive Vas Narasimhan have been marred by aprized psoriasis treatment that disappointed and a sharp slumpin sales by its U.S. generics unit. (NOVARTIS-RESULTS/ (UPDATE4, PIX), moved, by John Miller, 610 words)

More News
24 Aug 2018 11:54

LONDON MARKET MIDDAY: Stocks Up; Powell To Make Jackson Hole Debut

LONDON (Alliance News) - Stocks in London were marginally higher at midday on Friday ahead of a highly anticipated speech from the head of the US Federal Reserve.With US-China trade talks demoting a

Read more
24 Aug 2018 10:39

WINNERS & LOSERS SUMMARY: Shire Rises As US FDA Approves Takhzyro Drug

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 2.6%. The Irish pharmaceutical company said a

Read more
24 Aug 2018 08:38

LONDON MARKET OPEN: Stocks Mixed, Shire Rises After Drug Approval

LONDON (Alliance News) - Stock prices in London were mixed early Friday, as markets await US Federal Reserve Chair Jerome Powell's speech in Wyoming later in the day. In the large cap index rose

Read more
24 Aug 2018 08:06

FDA gives nod to Shire's TAKHZYRO treatment

(Sharecast News) - Shire announced on Friday that, following priority review, the US Food and Drug Administration (FDA) has approved the 'TAKHZYRO' (lanadelumab-flyo) injection for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years of age and older.

Read more
24 Aug 2018 07:41

LONDON MARKET PRE-OPEN: Slightly Lower Call Ahead Of Powell Speech

LONDON (Alliance News) - Stock prices in London are seen lower on Friday ahead of US Federal Reserve Chair Jerome Powell's speech later during the day, while in a quiet day for UK company news In

Read more
13 Aug 2018 10:31

WINNERS & LOSERS SUMMARY: Chemring Says Fatal Accident To Hurt Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------BAE up 0.8%. a

Read more
13 Aug 2018 09:21

Shire Partner Shionogi Files New Drug Application For Intuniv In Japan

LONDON (Alliance News) - Irish drugmaker Shire PLC said on Monday its Japanese partner Shionogi & Co Ltd has submitted a new drug application for the manufacture and marketing of Intuniv in is

Read more
13 Aug 2018 07:51

Shire and Shionogi apply to expand ADHD treatment to adults

(Sharecast News) - Shire and Shionogi have applied to expand the use in Japan of co-developed drug Intuniv to treat adults for attention deficit hyperactivity disorder.

Read more
31 Jul 2018 12:51

TOP NEWS: Shire Income Up In 2nd-Quarter Ahead Of Takeover By Takeda

LONDON (Alliance News) - Irish biotechnology company Shire PLC on Tuesday posted a more than doubled pretax income in the second quarter, ahead of its upcoming takeover by Takeda Pharmaceutical Co

Read more
31 Jul 2018 12:12

Shire posts 4 pct rise in Q2 earnings ahead of sale to Takeda

LONDON, July 31 (Reuters) - Shire, the London-listed pharmaceutical group being bought by Japan's Takeda, reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to just

Read more
31 Jul 2018 12:08

Shire's quarterly sales rise on immunology demand

(Sharecast News) - Shire reported healthy sales growth in the second quarter as the biotech company pressed ahead with its acquisition by Takeda of Japan.

Read more
31 Jul 2018 08:05

UPDATE 1-Takeda posts weakest Q1 profit in three years

* Q1 operating profit Y98.9 bln vs Y195 bln a year earlier * Takeda booked gains from asset sales a year earlier (Adds details) TOKYO, July 31 (Reuters) - Japan's Takeda Co Ltd a

Read more
25 Jul 2018 07:00

RPT-ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more
24 Jul 2018 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 25 July GlaxoSmithKlineHalf Year Results (at 1200 BST)Vodafone GroupTrading 26

Read more
24 Jul 2018 15:08

ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.